Kumar, V., Poonam, Prasad, A. K. & Parmar, V. S. Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Nat. Product. Rep. 20, 565–583 (2003).

CAS  Article  Google Scholar 

Han, J., Xian, Z., Zhang, Y., Liu, J. & Liang, A. Systematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms. Front. Pharmacol. 10, 648 (2019).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Michl, J. et al. LC-MS- and 1H NMR-based metabolomic analysis and in vitro toxicological assessment of 43 Aristolochia species. J. Nat. Products 79, 30–37 (2016).

CAS  Article  Google Scholar 

Michl, J., Bello, O., Kite, G. C., Simmonds, M. S. J. & Heinrich, M. Medicinally used Asarum species: high-resolution LC-MS analysis of aristolochic acid analogs and in vitro toxicity screening in HK-2 cells. Front. Pharmacol. https://doi.org/10.3389/fphar.2017.00215 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Scarborough, J. & Fernandes, A. Ancient medicinal use of Aristolochia: Birthwort’s tradition and toxicity. Pharm. Hist. 53, 3–21 (2011).

PubMed  Google Scholar 

Tomlinson, T., Fernandes, A. & Grollman, A. P. Aristolochia herbs and iatrogenic disease: the case of Portland’s powders. Yale J. Biol. Med. 93, 355–363 (2020).

PubMed  PubMed Central  Google Scholar 

Grollman, A. P., Scarborough, J. & Jelaković, B. In: Advances in Molecular Toxicology Vol. 3 211–227 (Elsevier, 2009).

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Pharmaceuticals. Volume 100A. A review of human carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum. 100, 1–401 (2012). In this volume of the IARC Monographs, the Working Group on the Evaluation of Carcinogenic Risks to Humans conducts a re-evaluation of AA and determines that the evidence available warrants its classification as a group 1 carcinogen.

PubMed Central  Google Scholar 

Gold, L. S. & Slone, T. H. Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert. N. Engl. J. Med. 349, 1576–1577 (2003).

CAS  PubMed  Article  Google Scholar 

Arlt, V. M., Stiborova, M. & Schmeiser, H. H. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 17, 265–277 (2002).

CAS  PubMed  Article  Google Scholar 

Ng, A. W. et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci. Transl. Med. 9, eaan6446 (2017). This study reports that an alarmingly high proportion (78%) of HCCs from patients treated in Taiwan harboured the AA mutational signature, and was among the first to examine the disparities in the occurrence of the AA mutational signature between patients with HCC in different countries.

PubMed  Article  CAS  Google Scholar 

Martena, M. J. et al. Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market. Anal. Bioanal. Chem. 389, 263–275 (2007).

CAS  PubMed  Article  Google Scholar 

Debelle, F. D., Vanherweghem, J.-L. & Nortier, J. L. Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 74, 158–169 (2008).

CAS  PubMed  Article  Google Scholar 

Wu, L. et al. An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids. Sci. Rep. 5, 11318 (2015).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zhang, H. M. et al. Recognition of the toxicity of aristolochic acid. J. Clin. Pharm. Ther. 44, 157–162 (2019).

PubMed  Article  CAS  Google Scholar 

Vaclavik, L., Krynitsky, A. J. & Rader, J. I. Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high-performance liquid chromatography–multistage fragmentation mass spectrometry. Food Addit. Contam. Part. A Chem. Anal. Control. Expo. Risk Assess. 31, 784–791 (2014).

CAS  PubMed  Article  Google Scholar 

Schaneberg, B. T. & Khan, I. A. Analysis of products suspected of containing Aristolochia or Asarum species. J. Ethnopharmacol. 94, 245–249 (2004).

CAS  PubMed  Article  Google Scholar 

Cachet, X. et al. Detection of aristolochic acids I and II in “Chiniy-trèf”, a traditional medicinal preparation containing caterpillars feeding on Aristolochia trilobata L. in Martinique, French West Indies. Toxicon https://doi.org/10.1016/j.toxicon.2016.02.013 (2016).

Article  PubMed  Google Scholar 

Riffault-Valois, L. et al. Health risk associated with the oral consumption of “Chiniy-tref”, a traditional medicinal preparation used in Martinique (French West Indies): qualitative and quantitative analyses of aristolochic acids contained therein. Toxicon 172, 53–60 (2019).

CAS  PubMed  Article  Google Scholar 

Ioset, J. R., Raoelison, G. E. & Hostettmann, K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem. Toxicol. 41, 29–36 (2003).

CAS  PubMed  Article  Google Scholar 

Cheung, T. P., Xue, C., Leung, K., Chan, K. & Li, C. G. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products — a consequence of inappropriate nomenclature and imprecise labelling? Clin. Toxicol. 44, 371–378 (2006).

Article  CAS  Google Scholar 

Abdullah, R., Diaz, L. N., Wesseling, S. & Rietjens, I. M. C. M. Risk assessment of plant food supplements and other herbal products containing aristolochic acids using the margin of exposure (MOE) approach. Food Addit. Contam. Part. A 34, 135–144 (2017).

CAS  Google Scholar 

Liu, J., Liu, Y., Wu, Y., Dai, Z. & Ma, S. Rapid analysis of aristolochic acid analogues in traditional Chinese patent medicine by LC-MS/MS. J. Anal. Methods Chem. Anal. Control Expo. Risk Assess. 2020, 8823596 (2020).

Google Scholar 

Michl, J. et al. Is aristolochic acid nephropathy a widespread problem in developing countries?: a case study of Aristolochia indica L. in Bangladesh using an ethnobotanical–phytochemical approach. J. Ethnopharmacol. 149, 235–244 (2013).

CAS  PubMed  Article  Google Scholar 

Maggini, V., Menniti-Ippolito, F. & Firenzuoli, F. Aristolochia, a nephrotoxic herb, still surfs on the Web, 15 years later. Intern. Emerg. Med. 13, 811–813 (2018).

PubMed  Article  Google Scholar 

Shibutani, S. et al. Selective toxicity of aristolochic acids I and II. Drug Metab. Dispos. 35, 1217–1222 (2007).

CAS  PubMed  Article  Google Scholar 

Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821–836.e16 (2019).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wu, S. Two cases of acute renal failure caused by mutong. Jiang Xi Zhong Yi 10, 12–14 (1964).

Google Scholar 

Hong, Y., Huang, Y. & Wang, Y. Over-dose of mutong causes renal failure and death. Zhe Jiang Zhong Yi Za Zhi 8, 32 (1965).

Google Scholar 

Zhou, F., Lu, H. & Nie, C. Toxicity of mutong causes acute renal failure. Zhonghua Shenzanbing Za Zhi 4, 223–224 (1988).

Google Scholar 

Poon, W.-T., Lai, C.-K. & Chan, A. Y.-W. Aristolochic acid nephropathy: the Hong Kong perspective. Hong. Kong J. Nephrol. 9, 7–14 (2007).

Article  Google Scholar 

Jackson, L., Kofman, S., Weiss, A. & Brodovsky, H. Aristolochic acid (Nsc-50413): phase I clinical study. Cancer Chemother. Rep. 42, 35–37 (1964).

CAS  PubMed  Google Scholar 

Kupchan, S. M. & Doskotch, R. W. Tumor inhibitors. I. Aristolochic acid, the active principle of Aristolochia indica. J. Med. Pharm. Chem. 91, 657–659 (1962).

CAS  PubMed  Article  Google Scholar 

Ivić, M. Etiology of endemic nephropathy. Lijec. Vjesn. 91, 1273–1281 (1969).

PubMed  Google Scholar 

Vanherweghem, J.-L. et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341, 387–391 (1993).

CAS  PubMed  Article  Google Scholar 

Vanherweghem, J.-L. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J. Altern. Complement. Med. 4, 9–13 (1998).

CAS  PubMed  Article  Google Scholar 

Depierreux, M., Van Damme, B., Houte, K. V. & Vanherweghem, J. L. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am. J. Kidney Dis. 24, 172–180 (1994).

CAS  PubMed  Article  Google Scholar 

Cosyns, J. P. et al. Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int. 45, 1680–1688 (1994). The authors examine the renal cortex specimens from individuals affected by the Belgian outbreak of AAN and report the first link connecting AAN to endemic nephropathy.

CAS  PubMed  Article  Google Scholar 

Nortier, J. L. et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342, 1686–1692 (2000). This study reports that patients with AAN face a high risk of developing urothelial carcinoma.

CAS  PubMed  Article  Google Scholar 

Cosyns, J.-P., Jadoul, M., Squifflet, J.-P., Wese, F.-X. & van Ypersele de Strihou, C. Urothelial lesions in Chinese-herb nephropathy. Am. J. Kidney Dis. 33, 1011–1017 (1999).

CAS  PubMed  Article  Google Scholar 

Lemy, A. et al. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. Am. J. Kidney Dis. 51, 471–477 (2008).

PubMed  Article  Google Scholar 

Sun, M. et al. Analysis of potential risk factors for cancer incidence in patients with aristolochic acid nephropathy from Wenzhou, China. Ren. Fail. 37, 209–213 (2015).

PubMed  Article  Google Scholar 

Yang, C.-S., Lin, C.-H., Chang, S.-H. & Hsu, H.-C. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am. J. Kidney Dis. 35, 313–318 (2000).

CAS  PubMed  Article